Baclofen for psychogenic movement disorders

Baclofen is a muscle relaxant drug used to treat muscle spasms. It is primarily used to relieve muscle spasms in the brain, and has been found to decrease the frequency and severity of spasticity in patients with multiple sclerosis, spinal cord injuries, or other spinal cord diseases. Baclofen also helps to treat symptoms of depression, anxiety, and other mental illnesses such as psychosis and anxiety. It has been approved by US FDA for treating alcohol addiction and other CNS conditions such as attention deficit hyperactivity disorder and attention deficit hyperactivity disorder (ADHD).

Baclofen is available as an oral tablet, as a liquid solution, and as a suspension. It is typically taken orally, with or without food, approximately 30 minutes to 1 hour before a meal. It is important to follow the dosage instructions provided by your doctor, and to take Baclofen exactly as prescribed by your doctor. Your dosage may need to be adjusted if it is not within the approved dosage range. To treat muscle spasms, take Baclofen exactly as directed on the label. Do not adjust your dosage or stop using it without your doctor’s approval.

Baclofen may cause mild or serious side effects. Although Baclofen is generally well-tolerated, some rare but serious side effects can occur. These include: severe allergic reactions (such as anaphylaxis), symptoms of kidney or liver disease, and changes in blood pressure or heart rate.

It is important to mention that Baclofen should only be used under the guidance of a healthcare professional. They will be able to advise you on the most appropriate dosage and make sure that you understand the risks and benefits of taking this medication. Do not stop using this medicine without consulting your doctor’s guidance.

Baclofen is not a miracle drug. Some patients experience muscle stiffness and spasms while taking it. However, it is not a drug that can be stopped suddenly and safely. It may take several weeks for Baclofen to start working and stop causing side effects.

References

Medically reviewed by. Last updated on July 10, 2024.

Citation

Baclofen (Mounjaro) is a muscle relaxant that helps the body get rid of spasticity, and is used to treat multiple sclerosis and other conditions.

Baclofen (Mounjaro) is an oral drug that is used to treat multiple sclerosis and other conditions.

Last updated on July 10, 2024All drugs interact to affect how your body processes medications. Tell your doctor, pharmacist, or health care provider if you are taking any of these medications:
  • isocarboxazid (Marplan);
  • isobarbital (Spanest);
  • hydrocodone (Decadron);
  • hydrocodone-hydrostatic (Durex);
  • hydrocortisone (Voltaren)
  • isoproterenol (Nardil);

Interactions between medications can increase the risk of serious side effects. Be sure to tell your doctor about all the medications you are taking, as certain drugs can interact with each other. If you are not sure if a medication isInteractions with medications can increase the risk of serious side effects. If you are not sure if a medication is Interactions with each other, talk to your doctor before taking any medication.

Inform your doctor about all the medications you are taking, including over-the-counter and herbal medications. Your doctor may want to change your dose of medication, or you may be prescribed a different medication.

Inform your doctor about all the over-the-counter and herbal medications you are taking. Your doctor may change the dose of medication, or you may be prescribed a different medication.

Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

Baclofen (brand name Lioresal) is a medication used to treat muscle spasms caused by certain conditions in the central nervous system (CNS). It is a muscle relaxant that helps to alleviate the discomfort of muscle stiffness and spasms. In some cases, it may also be used to help with spasms that occur due to other conditions.

Baclofen is available in the form of a liquid or tablet that is swallowed and can be easily swallowed with or without food. The medication is available in the form of a liquid or tablet and should be taken with food or a large meal. It is also available in the form of an injection.

If you are unsure whether you are allergic to Lioresal or to Baclofen or if you have a specific condition that is causing your spasticity, it is recommended to consult with a doctor or healthcare professional before taking Lioresal. They will be able to provide you with the necessary information before you start taking Lioresal. Lioresal may also have side effects such as dizziness, drowsiness, or difficulty concentrating. It is important to discuss any concerns with a healthcare professional before taking Lioresal. They can provide you with information on the risks associated with using Lioresal.

If you are not sure if you are allergic to Lioresal or if you have a specific condition that is causing your spasticity, it is recommended to consult with a doctor or healthcare professional before taking Lioresal. Lioresal can cause side effects such as dizziness, drowsiness, or difficulty concentrating.

It is also important to tell your doctor about any other medications you are taking. This will help them to know if you are taking any other medications. It is also important to tell your doctor about any other supplements you are taking.

Baclofen is also available in the form of liquid and tablet that is swallowed and can be easily swallowed with or without food.

If you are unsure whether you are allergic to Lioresal or if you have a specific condition that is causing your spasticity, it is recommended to consult with a doctor or healthcare professional before taking Lioresal.

VIDEO

Baclofen Tablets 20 mg by Teva is a muscle relaxer and antispastic agent. Baclofen is used to treat muscle symptoms caused by multiple sclerosis, including spasm, pain, and stiffness. Baclofen may also be used for purposes not listed in this medication guide.

Each tablet, for oral administration, contains 20 mg baclofen, USP. In addition, each tablet contains the following inactive ingredients: microcrystalline cellulose, pregelatinized starch, colloidal silicon dioxide, and magnesium stearate.

Baclofen tablets USP should be stored at room temperature, protected from light, and away from children.

It is not known if this medication is more effective than other available preparations.

Adults

Adults ( ≥ 18 years of age)

Take one tablet once a day.

Take special care in the administration of Baclofen tablets USP.

The dosage is based on your medical condition and response to treatment. Your doctor may adjust your dose based on your treatment goals, How you respond to Baclofen tablets USP, and any history of allergic reactions.

Your doctor may monitor you more closely by tracking your blood pressure (SBP) and liver function (ALT) tests. Check your blood pressure regularly to be able to tell when the dose's going to be effective. If the dose is too high, discuss a different dosage with your doctor or health care provider.

Children and Adults

The correct dosage for your child depends on their weight and age. The dosage for each child will be determined by their age and weight.

If you're a child, your doctor may start you at a lower dose and gradually increase your dose. Your doctor may gradually reduce your dose. If your child’s dose isn’t changing, your doctor may start you off with a higher dose and gradually increase your dose. Talk to your doctor about adjusting your dose.

If your child’s dose isn’t changing, your doctor may gradually increase their dose. Your doctor or health care provider may call your child's doctor to discuss how your child’s dose will go.

Your doctor will help determine how often you need to take Baclofen tablets USP to relieve your child's symptoms. If you experience pain, stiffness, or swelling in your child’s body after taking Baclofen tablets USP, contact your doctor immediately.

If your child experiences any of these symptoms, immediately contact your doctor or health care provider. Your doctor may refuse your child's treatment if your child experiences these symptoms. Your child's doctor will tell your child's doctor not to treat these symptoms.

Children and Adolescents only

Baclofen tablets USP is excreted in the body in the following elimination rates:

Your body will start to absorb Baclofen in the first few days of taking it, and the absorption rate may begin to slow. If you miss a dose, take it as soon as possible. If it's almost time for your next dose, skip the missed dose and go back to the normal schedule. Do not take a double dose to make up for a missed one.

To reduce the risk of side effects, your doctor may increase your daily dose. For example, if you have to take a 100 mg tablet once daily, you should take the 100 mg tablet twice daily for a total of 100 mg.

If you take Baclofen tablets USP regularly, your doctor will likely lower your dose slowly to help minimize the risk of side effects. Your doctor will gradually lower your dose. However, you should always follow their advice.

Do not use Baclofen tablets USP if you:

• Have liver problems

• Are allergic to Baclofen, other muscle relaxers or antispasmodics

• Are a smoker

• Are allergic to other muscle relaxants such as ibuprofen or aspirin

• Are allergic to other treatments for spasm (such as sprains, strains, or clenching).

Introduction

Baclofen is an antispastic agent. It inhibits the release of GABA in the brain, enhancing excitatory neurotransmitters.

Baclofen is considered to be one of the first-line treatment for severe spasticity caused by multiple sclerosis (MS).The drug is approved by the FDA for the treatment of spinal spasticity, although there is a lack of data regarding its use in the management of severe MS.

In fact, there are limited data on the use of baclofen for MS treatment. In clinical trials, a baclofen-associated spasticity was observed in patients with spinal spasticity who were treated with a single dose of baclofen (25 mg) for 6 weeks. The dose was then adjusted according to the severity of the spasticity and the response of the patient.

In this study, we evaluated the efficacy and safety of a single dose of baclofen in patients with severe MS who were treated with a baclofen-associated spasticity.

Methods

Study design and participants

A total of 769 patients with MS who underwent a baclofen-associated spasticity treatment were included in this study.

Of these 769 patients, 782 patients (83.5%) were treated with baclofen (25 mg,n= 682) or placebo (control group, n= 782). The primary endpoint was clinical remission (defined as the absence of any clinical symptoms after 12 months). Secondary outcomes were the change from baseline in the score on the Disability Scale (DS) (0-2 scale), global status on the Disability Scale (GS) (0-2 scale), and the Global Assessment for Emotional Neurosis Scale (GSE-2).

To evaluate the safety and efficacy of the baclofen-induced spasticity treatment, we reviewed the medical records of all patients treated with baclofen and all patients who responded to the treatment in terms of a change from baseline to the end of the study. The study was conducted in accordance with the Declaration of Helsinki. The inclusion criteria were patients who had at least 3 months of improvement from baseline on theDS and GGE-2 scales. The exclusion criteria were patients who had a history of adverse reactions to baclofen during treatment with baclofen.

Patients who were treated with baclofen and had a history of an adverse reaction to the medication were excluded from the study. In addition, patients were excluded if they were unable to be discharged home from the hospital, were pregnant or breastfeeding, had a history of serious adverse reactions, or had a history of muscle disorders. Finally, patients were enrolled in the study.

Interventions

Study design

We enrolled patients with a first attempt of the treatment of severe MS. We used a multidisciplinary team of specialists with experience in the treatment of MS. We included patients who presented to the hospital with signs or symptoms of a primary or secondary diagnosis of the disease, who received baclofen-associated spasticity treatment, or who were prescribed baclofen.

Study population

We included patients who presented to the hospital with signs or symptoms of a primary or secondary diagnosis of MS. Patients were randomly assigned to receive a single dose of baclofen (25 mg) or a placebo (n= 682).

Treatment duration

The duration of baclofen-induced spasticity treatment was based on the duration of the study period. We also included patients who were prescribed baclofen (n= 782) or placebo (n= 782) for 6 weeks. The duration of the study period was divided into 4 weeks, 6 weeks, 10 weeks, and 20 weeks. The duration of the study period was also divided into two phases: a period of 2 weeks (in which the treatment was stopped) and a period of 6 weeks (in which the baclofen-induced spasticity was started).

Primary efficacy measure

The primary efficacy measure was the change from baseline in theDS and GGE-2 scales at 3, 6, and 12 months after the last dose. Secondary efficacy measures included the changes from baseline to the end of the study.

What is this medication?

Baclofen is a medication that belongs to a group of drugs known as "gastric bandage" or "tussle". It is used to treat. The use of this medication can also be dangerous to the. In this case, baclofen may be considered a "baclofen-assisted treatment" or.

This medication should not be taken by anyone with liver or kidney problems.

Baclofen is an antispasmodic medication. This medication is not a depressant and does not act as an opioid.

This medication does not cause an allergic reaction. If you are allergic to baclofen or any other medications, please tell your doctor before taking this medication. Symptoms of an allergic reaction may include:

Symptoms of an allergic reaction to this medication may include:

If you are allergic to baclofen, do not use this medication.

If you have liver problems, please tell your doctor before taking this medication.

If you are taking baclofen-assisted treatment, please tell your doctor.